Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions

How to Cite

OrthoEvidence. Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions. ACE Report. 2022;231(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14583

Study Type:Therapy

OE Level Evidence:1

Journal Level of Evidence:1

Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial (ZoMARS)

J Bone Miner Res. 2022 Mar;37(3): 420-427.

Contributing Authors:
L Seefried F Genest J Baumann A Heidemeier R Meffert F Jakob

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

48 patients with painful bone marrow lesions were randomized to receive Vitamin D and calcium supplementation plus a single dose of intravenous Zoledronic acid (n=34) or placebo (n=14). The primary outcome of interest was the change in volume/size of the lesion. Secondary outcomes of interest included pain on a Visual Analog Scale (VAS), pain disability index (PDI), bone-specific quality of life q...